Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (221-230 of 1,622) with videos related to

Pageof 163
Sort By:
Current Oncology Reports|April 2, 2008
Combination versus sequential chemotherapy administration: is it time for a reevaluation of the issue?Maurie Markman
British Journal of Cancer|March 20, 2008
Further evidence of clinical benefit associated with participation in phase I oncology trialsM Markman
Oncology|March 12, 2008
Reducing the worldwide burden of cancerMaurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
An argument in support of cost-effectiveness analysis in oncologyM Markman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2008
Maintenance chemotherapy in advanced ovarian cancer: the US experienceM Markman
Gynecologic Oncology|January 19, 2008
Re: "Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials"Maurie Markman
Cleveland Clinic Journal of Medicine|February 1, 1997
The dilemma of evaluating and treating cancer of unknown primary siteM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Eighty-seventh annual meeting of the American Association for Cancer Research. Washington, D,C., 20-24 April 1996M Markman
Cleveland Clinic Journal of Medicine|April 1, 1997
Calculating cancer risk: it is harder than it seemsM Markman
Seminars in Oncology|February 1, 1997
Topotecan: an important new drug in the management of ovarian cancerM Markman
Pageof 163

Showing results (221-230 of 1,622) with videos related to

Sort By:
Pageof 163
Current Oncology Reports|April 2, 2008
Combination versus sequential chemotherapy administration: is it time for a reevaluation of the issue?Maurie Markman
British Journal of Cancer|March 20, 2008
Further evidence of clinical benefit associated with participation in phase I oncology trialsM Markman
Oncology|March 12, 2008
Reducing the worldwide burden of cancerMaurie Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
An argument in support of cost-effectiveness analysis in oncologyM Markman
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2008
Maintenance chemotherapy in advanced ovarian cancer: the US experienceM Markman
Gynecologic Oncology|January 19, 2008
Re: "Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials"Maurie Markman
Cleveland Clinic Journal of Medicine|February 1, 1997
The dilemma of evaluating and treating cancer of unknown primary siteM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Eighty-seventh annual meeting of the American Association for Cancer Research. Washington, D,C., 20-24 April 1996M Markman
Cleveland Clinic Journal of Medicine|April 1, 1997
Calculating cancer risk: it is harder than it seemsM Markman
Seminars in Oncology|February 1, 1997
Topotecan: an important new drug in the management of ovarian cancerM Markman
Pageof 163